Clinicians Use SSRIs Off- Label in Many Conditions
As the body of data has grown, clinicians’ propensity to use selective serotonin reuptake inhibitors off-label has increased
Source: pharmacytimes.com
Stay updated with breaking news from Int Clin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As the body of data has grown, clinicians’ propensity to use selective serotonin reuptake inhibitors off-label has increased
Here’s why you should initiate clozapine sooner in patients with treatment-resistant schizophrenia.
Social anxiety disorder: an underappreciated and misunderstood condition.
PME affects many women, yet it remains under-recognized in clinical practice and in research.
The estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.